BusinessCrown Bioscience Announces Collaboration to Develop Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) AntibodyBy Nasdaq OMXMay 8, 2017, 2:04 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at Three Prominent Industry Conferences in May 2017By Nasdaq OMXMay 8, 2017, 12:31 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at Three Prominent Industry Conferences in May 2017By Nasdaq OMXMay 8, 2017, 12:31 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessPreclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
